(Q47644869)

English

The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.

scientific article published on 5 May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

author name string

John B Walker

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

Laszlo Bajzar

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

language of work or name

0 references

publication date

5 May 2004

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

279

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

27

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

27896-27904

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

A kinetic analysis of the tissue plasminogen activator and DSPAalpha1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradation products of varying size

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Purification and characterization of a new arginine carboxypeptidase in human serum

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Pro-carboxypeptidase R cleaves bradykinin following activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Activation and characterization of procarboxypeptidase B from human plasma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Affinity-chromatographic purification of human alpha 2-antiplasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

A simple method for the preparation of homogeneous phospholipid vesicles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Thresholds in development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Heat stability of carboxypeptidase R of experimental animals

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401027200

21 January 2018

Identifiers

10.1074/JBC.M401027200

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15128744

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47644869&oldid=1769451287"